Advantage of whole-mount histopathology in prostate cancer: current applications and future prospects.

Journal: BMC cancer
Published Date: Apr 11, 2024

Abstract

BACKGROUND: Whole-mount histopathology (WMH) has been a powerful tool to investigate the characteristics of prostate cancer. However, the latest advancement of WMH was yet under summarization. In this review, we offer a comprehensive exposition of current research utilizing WMH in diagnosing and treating prostate cancer (PCa), and summarize the clinical advantages of WMH and outlines potential on future prospects.

Authors

  • Lewei Duan
    Department of Urology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China.
  • Zheng Liu
    ICSC World Laboratory, Geneva, Switzerland.
  • Fangning Wan
    Department of Urology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China. fnwan06@fudan.edu.cn.
  • Bo Dai
    School of Computer Science and Engineering, University of Electronic Science and Technology of China, Chengdu, 611731, China.

Keywords

External Resources

Popular Topics
Recent Journals